share_log

Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target

Benzinga ·  Mar 25 23:09

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment